QDEL
HEALTHCAREQuidel Corporation
AI Insight
What's Moving QDEL Today?
No stock-specific AI insight has been generated for QDEL yet. Check back soon — insights are generated from recent news analysis.
Market Briefings featuring QDEL
52-Week Range
$9.92$35.58
$17.68
Fundamentals
Market Cap$940M
P/E Ratio—
EPS$-17.85
Dividend Yield—
Dividend / Share—
ROE-49.9%
Profit Margin-45.6%
Debt / Equity—
Trading
Volume536K
Avg Volume (10D)—
Shares Outstanding68.2M
QDEL News
24 articles- Jefferies on QuidelOrtho (QDEL): 'we view a potential sale as a net positive'StreetInsider·Jun 29, 2026
- 1 Unprofitable Stock to Consider Right Now and 2 We IgnoreYahoo Finance·Jun 23, 2026
- QuidelOrtho Appoints Micah Young as Chief Financial OfficerYahoo Finance·Jun 23, 2026
- 3 Russell 2000 Stocks We Steer Clear OfYahoo Finance·Jun 22, 2026
- AtriCure (ATRC) Soars 6.2%: Is Further Upside Left in the Stock?Yahoo Finance·Jun 19, 2026
- Reasons to Retain QuidelOrtho Stock in Your Portfolio for NowYahoo Finance·Jun 17, 2026
- Is the Options Market Predicting a Spike in QuidelOrtho Stock?Yahoo Finance·Jun 12, 2026
- 3 Value Stocks We Approach with CautionYahoo Finance·Jun 11, 2026
- 1 Stock Under $50 with Exciting Potential and 2 Facing ChallengesYahoo Finance·Jun 8, 2026
- QuidelOrtho and Allo Hope Foundation partner to advance prenatal care for maternal alloimmunizationSelectScience·Jun 8, 2026
- A Look At QuidelOrtho (QDEL) Valuation After Recent Share Price Rebound And Longer Term WeaknessYahoo Finance·Jun 8, 2026
- QuidelOrtho (QDEL) Up 24.1% Since Last Earnings Report: Can It Continue?Yahoo Finance·Jun 4, 2026
- QuidelOrtho's Respiratory Exposure Remains a Key Near-Term RiskTradingView·Jun 4, 2026
- QuidelOrtho and Allo Hope Foundation Join Forces to Advance Education, Connection and Early Testing for Alloimmunized PregnanciesYahoo Finance·Jun 2, 2026
- McIntyre Partnerships’ Analysis on QuidelOrtho Corporation (QDEL)Yahoo Finance·Jun 1, 2026
- When Blood Compatibility Becomes a Pregnancy RiskYahoo Finance·May 21, 2026
- QuidelOrtho to Participate in Upcoming June 2026 Investor ConferencesYahoo Finance·May 20, 2026
- QuidelOrtho Corp stock (US7476011036): analysts divided as short interest climbs and sentiment weakensAD HOC NEWS·May 16, 2026
- 5 Insightful Analyst Questions From QuidelOrtho’s Q1 Earnings CallYahoo Finance·May 15, 2026
- Pregnancy Detection Kits Market Analysis Report 2026 - Competitive Landscape, Opportunities, and Forecasts, 2021-2025 & 2025-2031GlobeNewswire Inc.·May 8, 2026
- Oracle upgraded, Planet Fitness downgraded: Wall Street's top analyst callsYahoo Finance·May 7, 2026
- QDEL Stock Down as Q1 Earnings Miss Estimates, Revenues Down Y/YYahoo Finance·May 6, 2026
- QuidelOrtho Q1 Earnings Call HighlightsMarketbeat·May 6, 2026
- QuidelOrtho Corporation Q1 2026 Earnings Call SummaryMoby·May 6, 2026
All 24 articles loaded
Price Data
Open$18.13
Previous Close$18.23
Day High$18.28
Day Low$16.94
52 Week High$35.58
52 Week Low$9.92
52-Week Range
$9.92$35.58
$17.68
Fundamentals
Market Cap$940M
P/E Ratio—
EPS$-17.85
Dividend Yield—
Dividend / Share—
ROE-49.9%
Profit Margin-45.6%
Debt / Equity—
Trading
Volume536K
Avg Volume (10D)—
Shares Outstanding68.2M
About Quidel Corporation
Quidel Corporation develops, manufactures, and markets diagnostic testing solutions for infectious disease, cardiology, thyroid, general and women's health, eye health, gastrointestinal disease, and toxicology applications globally. The company is headquartered in San Diego, California.
HEALTHCAREMEDICAL DEVICES
Company Details
Security TypeCommon Stock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICMEDICAL DEVICES
CIK—
Composite FIGI—
Share Class FIGI—